WO2002062982A1 - A yeast having b cell immune regulation activity and its preparation method and application thereof - Google Patents

A yeast having b cell immune regulation activity and its preparation method and application thereof Download PDF

Info

Publication number
WO2002062982A1
WO2002062982A1 PCT/CN2001/000115 CN0100115W WO02062982A1 WO 2002062982 A1 WO2002062982 A1 WO 2002062982A1 CN 0100115 W CN0100115 W CN 0100115W WO 02062982 A1 WO02062982 A1 WO 02062982A1
Authority
WO
WIPO (PCT)
Prior art keywords
yeast
gene
cell immune
specific
cell
Prior art date
Application number
PCT/CN2001/000115
Other languages
French (fr)
Chinese (zh)
Inventor
Kamfu Wong
Original Assignee
Six Forest Bio-Science Institute Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Six Forest Bio-Science Institute Limited filed Critical Six Forest Bio-Science Institute Limited
Priority to PCT/CN2001/000115 priority Critical patent/WO2002062982A1/en
Publication of WO2002062982A1 publication Critical patent/WO2002062982A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves

Abstract

The invention relate to a method adoptting simulative bio-electric-wave information, which activates recessive gene of normal yeast, and converts normal yeast to specific yeast, the specific protein(enzyme) expressed by specific yeast respectively have the function of activates, regulate, correct B cell immune gene, T cell immune gene, K cell immune gene and NK cell variant gene whose immunological competence is low. The specific yeast be made into biologicals to regulate body immune gene for reestablishing body immune function, and cure the patient. The biologicals can be applied for treatment of various kinds of diseases, such as tumour, uremia, hepatitis, senile dementia, gastroenteropathy, diabetes and neur-disorder, it has remarkable availability, no toxicity and side effect.
PCT/CN2001/000115 2001-02-08 2001-02-08 A yeast having b cell immune regulation activity and its preparation method and application thereof WO2002062982A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/CN2001/000115 WO2002062982A1 (en) 2001-02-08 2001-02-08 A yeast having b cell immune regulation activity and its preparation method and application thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2001/000115 WO2002062982A1 (en) 2001-02-08 2001-02-08 A yeast having b cell immune regulation activity and its preparation method and application thereof

Publications (1)

Publication Number Publication Date
WO2002062982A1 true WO2002062982A1 (en) 2002-08-15

Family

ID=4574769

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2001/000115 WO2002062982A1 (en) 2001-02-08 2001-02-08 A yeast having b cell immune regulation activity and its preparation method and application thereof

Country Status (1)

Country Link
WO (1) WO2002062982A1 (en)

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1375652A3 (en) * 2002-06-28 2004-01-07 Ultra Biotech Limited Oral compositions for HIV-Infected Subjects
EP1375651A3 (en) * 2002-06-28 2004-01-07 Ultra Biotech Limited Oral compositions for white blood cell activation and proliferation
US6984507B2 (en) 2003-06-11 2006-01-10 Ultra Biotech Limited Biological compositions and methods for treatment of lung cancer
US6984508B2 (en) 2003-06-11 2006-01-10 Ultra Biotech Limited Biological compositions and methods for treatment of cervical cancer
US6987012B2 (en) 2003-06-11 2006-01-17 Ultra Biotech Limited Biological compositions and methods for treatment of colorectal cancer
US6989253B2 (en) 2003-06-11 2006-01-24 Ultra Biotech Limited Biological compositions and methods for treatment of testicular cancer
US7201906B2 (en) 2003-06-11 2007-04-10 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7204988B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7204986B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7204987B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Biological compositions and methods for treatment of prostate cancer
US7208158B2 (en) 2003-06-11 2007-04-24 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7214377B2 (en) 2003-06-11 2007-05-08 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7220416B2 (en) 2003-06-11 2007-05-22 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223405B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepareompositions comprising yeast treated with electromagnetic energy
US7223402B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223404B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223403B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223400B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223401B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7226600B2 (en) 2003-06-11 2007-06-05 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
WO2011023769A1 (en) * 2009-08-26 2011-03-03 Mb Milmed Ab Composition for treatment of neurodegenerative diseases or disorders, method and use comprising electromagnetically irradiated yeast

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09182582A (en) * 1996-01-05 1997-07-15 Kagaku Gijutsu Shinko Jigyodan Cell culturing method and device therefor

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09182582A (en) * 1996-01-05 1997-07-15 Kagaku Gijutsu Shinko Jigyodan Cell culturing method and device therefor

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DING ZHISHAN ET AL.: "Transforming yeast bioplast by ultrasonic-method", BIOTECHNOLOGY, vol. 6, no. 4, 1996, pages 41 - 43 *
GAO DAWEI ET AL.: "Effects of linear ultrasonic wave irradiation on the growth of saccharomyces cerevisiae", JOURNAL OF SOUTH CHINA UNIVERSITY OF TECHNOLOGY (NATURAL SCIENCE), vol. 27, no. 12, December 1999 (1999-12-01), pages 34 - 37 *

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1375652A3 (en) * 2002-06-28 2004-01-07 Ultra Biotech Limited Oral compositions for HIV-Infected Subjects
EP1375651A3 (en) * 2002-06-28 2004-01-07 Ultra Biotech Limited Oral compositions for white blood cell activation and proliferation
US6984507B2 (en) 2003-06-11 2006-01-10 Ultra Biotech Limited Biological compositions and methods for treatment of lung cancer
US6984508B2 (en) 2003-06-11 2006-01-10 Ultra Biotech Limited Biological compositions and methods for treatment of cervical cancer
US6987012B2 (en) 2003-06-11 2006-01-17 Ultra Biotech Limited Biological compositions and methods for treatment of colorectal cancer
US6989253B2 (en) 2003-06-11 2006-01-24 Ultra Biotech Limited Biological compositions and methods for treatment of testicular cancer
US7201906B2 (en) 2003-06-11 2007-04-10 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7204988B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7204986B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7204987B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Biological compositions and methods for treatment of prostate cancer
US7208158B2 (en) 2003-06-11 2007-04-24 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7214377B2 (en) 2003-06-11 2007-05-08 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7220416B2 (en) 2003-06-11 2007-05-22 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223405B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepareompositions comprising yeast treated with electromagnetic energy
US7223402B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223404B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223403B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223400B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223401B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7226600B2 (en) 2003-06-11 2007-06-05 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
WO2011023769A1 (en) * 2009-08-26 2011-03-03 Mb Milmed Ab Composition for treatment of neurodegenerative diseases or disorders, method and use comprising electromagnetically irradiated yeast
CN102481368A (en) * 2009-08-26 2012-05-30 密美德有限公司 Composition for treatment of neurodegenerative diseases or disorders, method and use comprising electromagnetically irradiated yeast
JP2013503138A (en) * 2009-08-26 2013-01-31 エムビー ミルメド エービー Compositions, methods and uses for the treatment of neurodegenerative diseases or disorders comprising electromagnetic radiation yeast
US9320768B2 (en) 2009-08-26 2016-04-26 Milmed Ab Composition for treatment of neurodegenerative diseases or disorders, method and use comprising electromagnetically irradiated yeast

Similar Documents

Publication Publication Date Title
WO2002062982A1 (en) A yeast having b cell immune regulation activity and its preparation method and application thereof
WO2002062984A1 (en) The yeast with immunoregulation activity to the k cell as well as the production method and the use thereof
WO2004047728A3 (en) Compositions and methods for the treatment of immune related diseases
WO2002062983A1 (en) A yeast with t cell immunoregulatory activity as well as the preparing method and the uses thereof
WO2002062985A1 (en) A yeast with nk cell immunoregulatory activity as well as the preparing method and the uses thereof
WO2002062981A1 (en) A yeast human immunoregulator and the method for preparing it
WO2003012057A3 (en) Antisense modulation of serum amyloid a4 expression
AU3642499A (en) Ste20-related protein kinases
WO2005002526A3 (en) Method and compositions for treatment of viral infections
WO2003030927A3 (en) Use of thymulin-like peptides for making pain-relieving medicines
WO1997011667A3 (en) Therapeutic applications using horse serum
AU2003228530A1 (en) Use of parapox b2l protein to modify immune responses to administered antigens
WO2005058945A3 (en) Gene variants coding for proteins from the metabolic pathway of fine chemicals
WO2002062946A3 (en) Identification of novel ms4a gene family members expressed by hematopoietic cells
WO2001040313A3 (en) Feline immunoregulatory proteins, nucleic acid molecules, and uses thereof
WO2002101068A3 (en) Process for the preparation of d-pantothenic acid and/or salts thereof
WO2003059387A3 (en) Combination comprising anti-cd52 antibodies and other therapeutic agents for treatment for multiple sclerosis
AU2001292310A1 (en) Method of regulating the activity of expression product of gene transferred intoliving body
WO2007092609A3 (en) Method for treating peripheral arterial disease with zinc finger proteins
WO2007044912A3 (en) Non-native constitutively active osteopontin
WO2005023979A3 (en) Isolated s. mansoni nucleic acid molecules and uses thereof
WO2002000853A3 (en) Regulation of human caspase-1-like protease
WO2001057186A3 (en) Methods and compositions for diagnosis and treatment of cancer based on esf
AU2003227053A1 (en) Yeast pheromones for the treatment of infectious diseases
WO2004048531A3 (en) Modulation of death-associated protein kinase 1 expression

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 69(1) EPC

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP